Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
AssigneeCavalier Pharmaceuticals
InventorThomas P. Kennedy
Life of this patent
Estimating the term…
Abstract
A method and medicament for the inhibition of neutrophil elastase and cathepsin G in mammals comprising administering a treatment effective amount of 2-O-desulfated heparin to a mammal in need thereof. The medicament preferably is administered by aerosolization or by intravenous (IV) injection. Preferably, the 2-O-desulfated heparin medicament includes a physiologically acceptable carrier which may be selected from the group consisting of physiologically buffered saline, normal saline, and distilled water. Additionally provided is a method of synthesizing 2-O-desulfated heparin.
Claims11
A method for inhibiting neutrophil elastase or cathepsin G in a mammal comprising administering to the mammal an inhibiting amount of partially desulfated heparin made by the process comprising alkalinizing a solution containing heparin to pH 13.
Dependencies are inferred from the claim text.